TWST
Twist Bioscience Corp
Key Financials
Operating Income
$-136259000
↑ 38.3%
Net Income
$-77670000
↑ 62.8%
Total Liabilities
$168.9M
↑ 19.3%
Shareholders' Equity
$473.0M
↑ 0.1%
EPS (Diluted)
$-1.30
↑ 63.9%
Cash & Equivalents
$183.0M
↓ 19.1%
Total Assets
$641.9M
↑ 4.5%
Operating Cash Flow
$-47628000.00
↑ 25.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 4/17/2026 | View on SEC |
| 4 | 4/16/2026 | View on SEC |
| 144 | 4/14/2026 | View on SEC |
| 4 | 4/13/2026 | View on SEC |
| 144 | 4/9/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 144 | 4/1/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 4 | 3/24/2026 | View on SEC |
| 4 | 3/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TWST |
| Company Name | Twist Bioscience Corp |
| CIK | 1581280 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | DE |
| Phone | 800-719-0671 |